1. Introduction — The coxib controversies

   • K D Rainsford

   EditorialNotes 01 September 2005 Pages: 331 - 341

2. The use of NSAIDs in rheumatic disorders 2005: a global perspective

   • Walter F Kean
   • W Watson Buchanan

   ReviewPaper 01 September 2005 Pages: 343 - 370

3. The murky waters of the coxibs: a review of the current state of play

   • Andrew J K Ostor
   • Brian L Hazleman

   ReviewPaper 01 September 2005 Pages: 371 - 380

4. The murky world of the COX-2-selective agents

   • Ingvar Bjarnason
   • Bjarni Thjodleifsson

   OriginalPaper 01 September 2005 Pages: 381 - 393

5. COX-2 controversy: where are we and where do we go from here?

   • Dinesh Khanna
   • Puja P Khanna
   • Daniel E Furst

   OriginalPaper 01 September 2005 Pages: 395 - 402

6. Coxibs and their aftermath: an (opinionated) commentary, based on some historical viewpoints

   • M Whitehouse

   OriginalPaper 01 September 2005 Pages: 403 - 417

7. COX-2 inhibitors: a story of greed, deception and death

   • Georges M Halpern

   OriginalPaper 01 September 2005 Pages: 419 - 425